DE69932920D1 - Neue dihydroxyhexansäurederivate - Google Patents

Neue dihydroxyhexansäurederivate

Info

Publication number
DE69932920D1
DE69932920D1 DE69932920T DE69932920T DE69932920D1 DE 69932920 D1 DE69932920 D1 DE 69932920D1 DE 69932920 T DE69932920 T DE 69932920T DE 69932920 T DE69932920 T DE 69932920T DE 69932920 D1 DE69932920 D1 DE 69932920D1
Authority
DE
Germany
Prior art keywords
dihydroxyhexanic
new
acid derivatives
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932920T
Other languages
English (en)
Other versions
DE69932920T2 (de
Inventor
Charles Kath
Frank Brown
Stanley Poss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE69932920D1 publication Critical patent/DE69932920D1/de
Application granted granted Critical
Publication of DE69932920T2 publication Critical patent/DE69932920T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
DE69932920T 1998-02-05 1999-01-18 Neue dihydroxyhexansäurederivate Expired - Lifetime DE69932920T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05
US73801P 1998-02-05
PCT/IB1999/000067 WO1999040061A2 (en) 1998-02-05 1999-01-18 Novel dihydroxyhexanoic acid derivatives

Publications (2)

Publication Number Publication Date
DE69932920D1 true DE69932920D1 (de) 2006-10-05
DE69932920T2 DE69932920T2 (de) 2007-02-08

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932920T Expired - Lifetime DE69932920T2 (de) 1998-02-05 1999-01-18 Neue dihydroxyhexansäurederivate

Country Status (37)

Country Link
EP (1) EP1051405B1 (de)
JP (1) JP3693916B2 (de)
KR (1) KR100385529B1 (de)
CN (1) CN1177834C (de)
AP (1) AP992A (de)
AR (1) AR016175A1 (de)
AT (1) ATE337307T1 (de)
AU (1) AU752407B2 (de)
BG (1) BG104726A (de)
BR (1) BR9907655A (de)
CA (1) CA2320388C (de)
DE (1) DE69932920T2 (de)
DZ (1) DZ2717A1 (de)
EA (1) EA003137B1 (de)
ES (1) ES2268847T3 (de)
GT (1) GT199900011A (de)
HK (1) HK1034969A1 (de)
HR (1) HRP20000529B1 (de)
HU (1) HUP0100832A3 (de)
IL (1) IL137330A0 (de)
IS (1) IS5562A (de)
MA (1) MA26603A1 (de)
MY (1) MY133125A (de)
NO (1) NO20003965D0 (de)
NZ (1) NZ505724A (de)
OA (1) OA11448A (de)
PA (1) PA8467301A1 (de)
PE (1) PE20000243A1 (de)
PL (1) PL342817A1 (de)
SK (1) SK11262000A3 (de)
TN (1) TNSN99013A1 (de)
TR (1) TR200002248T2 (de)
TW (1) TW470744B (de)
UA (1) UA57824C2 (de)
WO (1) WO1999040061A2 (de)
YU (1) YU47100A (de)
ZA (1) ZA99873B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044365A1 (en) * 1999-01-29 2000-08-03 Millennium Pharmaceuticals, Inc. Methods for preventing graft rejection and ischemia-reperfusion injury
PT1204643E (pt) * 1999-08-20 2008-09-15 Dow Agrosciences Llc Amidas aromáticas heterocíclicas fungicidas e suas composições, métodos de utilização e preparação
EP1498417A1 (de) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterozyklische Amid-Derivate
EA005320B1 (ru) 2000-02-04 2005-02-24 Пфайзер Продактс Инк. Производные гетероциклического амида
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
DE60238193D1 (de) 2001-06-22 2010-12-16 Pfizer Prod Inc Pharmazeutische zusammensetzungen, enthaltend adsorbate eines arzneimittels in amorpher form
JP2004534812A (ja) 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
JP2005527604A (ja) * 2002-05-14 2005-09-15 ファイザー・プロダクツ・インク ジヒドロフラン2オン誘導体の製造方法
WO2003095440A1 (en) * 2002-05-14 2003-11-20 Pfizer Products Inc. Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
CA2496441C (en) 2002-08-12 2010-03-16 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
MXPA05001781A (es) * 2002-08-12 2005-04-25 Pfizer Prod Inc Formas cristalinas de [4-carbamoil -1-(3- fluorobencil)-2, 7-dihidroxi- 7-metil- octil]-amida del acido quinoxalina-2- carboxilico.
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
PT708085E (pt) * 1994-10-19 2002-11-29 Novartis Ag Eteres antivirais de isosteros de substrato de aspartato protease
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
NO20003965L (de) 2000-10-03
KR100385529B1 (ko) 2003-05-27
CN1177834C (zh) 2004-12-01
NZ505724A (en) 2003-02-28
CN1290255A (zh) 2001-04-04
BG104726A (en) 2001-04-30
NO20003965D0 (no) 2000-08-04
TNSN99013A1 (fr) 2005-11-10
JP3693916B2 (ja) 2005-09-14
JP2002502839A (ja) 2002-01-29
PL342817A1 (en) 2001-07-02
ES2268847T3 (es) 2007-03-16
MA26603A1 (fr) 2004-12-20
HRP20000529A2 (en) 2001-08-31
CA2320388A1 (en) 1999-08-12
BR9907655A (pt) 2000-10-24
SK11262000A3 (sk) 2001-01-18
DE69932920T2 (de) 2007-02-08
TW470744B (en) 2002-01-01
EP1051405A2 (de) 2000-11-15
DZ2717A1 (fr) 2003-09-01
HUP0100832A2 (hu) 2002-02-28
PE20000243A1 (es) 2000-04-07
IL137330A0 (en) 2001-07-24
TR200002248T2 (tr) 2000-12-21
AP992A (en) 2001-08-06
OA11448A (en) 2003-11-18
PA8467301A1 (es) 2000-05-24
HK1034969A1 (en) 2001-11-09
YU47100A (sh) 2002-11-15
UA57824C2 (uk) 2003-07-15
IS5562A (is) 2000-07-14
CA2320388C (en) 2005-05-03
ZA99873B (en) 2000-08-04
WO1999040061A2 (en) 1999-08-12
EP1051405B1 (de) 2006-08-23
AP9901457A0 (en) 1999-03-31
HRP20000529B1 (en) 2004-12-31
EA003137B1 (ru) 2003-02-27
MY133125A (en) 2007-10-31
HUP0100832A3 (en) 2002-03-28
AU752407B2 (en) 2002-09-19
GT199900011A (es) 2000-07-20
EA200000741A1 (ru) 2001-02-26
KR20010040684A (ko) 2001-05-15
WO1999040061A3 (en) 1999-10-21
AU1778999A (en) 1999-08-23
AR016175A1 (es) 2001-06-20
ATE337307T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
ATE246674T1 (de) Neue 3-aryl-2-hydroxypropionsäure-derivate
ATE261429T1 (de) Neue 3-aryl-2-hydroxypropionsäure-derivate iii
EE200000573A (et) Asendatud indoolalkaanhapped
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO20010193D0 (no) Tiobenzimidazol-derivater
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
ATE236136T1 (de) Benzosulfonderivate
DE60015796D1 (de) Neue aminopropylphosphinsäuren
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ATE259810T1 (de) Phenyl-xanthinderivate
DE69920730D1 (de) Wässrige zusammensetzung
ATE337307T1 (de) Neue dihydroxyhexansäurederivate
ATE255098T1 (de) Substituierte chromanderivate
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DE69718338D1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DK1060183T3 (da) 5-deoxycytidinderivater
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate
SE9801991D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative II
BR1100830A (pt) Derivados de ácido heteroacético

Legal Events

Date Code Title Description
8364 No opposition during term of opposition